Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Image of the MS-UK Helpline button graphic containing a link to the Helpline page

Image of the New Pathways magazine button graphic containing a link to the New Pathways magazine page


A study published by researchers from Bristol University claims to show the immune system can be taught to stop treating harmless everyday proteins as if they were dangerous invasive diseases....

A team of scientists led by University of Virginia researchers say they have found a connection between a molecule found in the body’s immune system and social behaviour.

Working out of...

Symptoms of multiple sclerosis have long been linked with the body’s immune system, and immune response has also been linked to depression. Now researchers think it could be a shared pathological...

A comprehensive review article examining the role of gut bacteria and the viruses that infect them in the development and progression of MS, published in Journal of Interferon & Cytokine...

The European Commission (EC) has approved Zinbryta for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS).

Zinbryta, which is being developed by Biogen and...

Roche has announced that the European Medicines Agency (EMA) has validated the company’s Marketing Authorisation Application (MAA) of ocrelizumab for the treatment of relapsing multiple sclerosis...

Individuals with genetically increased body mass indexes are at a greater risk for developing multiple sclerosis (MS), according to analyses performed on two genome-wide association datasets....

The multiple sclerosis drug Gilenya may help patients by directly enhancing nerve regeneration and increasing myelination in a way that is partly independent of its anti-inflammatory properties....

Rituximab may be an possible treatment option for patients with relapsing-remitting multiple sclerosis (MS), researchers say, after phase II study findings found its efficacy in controlling...

Scientists of the Technical University of Munich (TUM) and the Max Planck Institute of Psychiatry have identified four new risk genes that are altered in German patients with multiple sclerosis (...

Pages

Live Chat Software by Click4Assistance UK